Cart
sales@molnova.com
Alphalipoic acid
CAS No. 62-46-4
Alphalipoic acid( —— )
Catalog No. M18917 CAS No. 62-46-4
Thioctic acid is an octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 42 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAlphalipoic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionThioctic acid is an octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes.
-
DescriptionThioctic acid is an octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorMultivitamin uptake inhibitor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number62-46-4
-
Formula Weight206.33
-
Molecular FormulaC8H14O2S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)CCCCC1CCSS1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ning-Ping Foo, et al. Toxicology Volume 282, Issues 1–2, 28 March 2011, Pages 39–46.
molnova catalog
related products
-
Casein kinase 1δ-IN-...
Casein kinase 1δ-IN-14 (WAY-637081) is a compound utilized in research to study atherosclerosis-related cardiovascular disease.
-
Isololiolide
Isololiolide has phytotoxicity, it inhibited seedling growth of cress and barnyard grass. It also showed in vitro activity against both trypomastigote and intracellular amastigotes of Trypanosoma cruzi, with IC50 values of 32 μM and 40 μM, respectively.
-
Ralinepag
Ralinepag is a potent, orally bioavailable and non-prostanoid prostacyclin (IP) receptor agonist, with EC50s of 8.5 nM, 530 nM and 850 nM for human and rat IP receptor and human DP1 receptor, respectively.
